Home › Chronic Myeloid Leukemia › Michigan
Chronic Myeloid Leukemia clinical trials in Michigan
7 studies for Chronic Myeloid Leukemia are looking for participants at sites in Michigan.
Cities in Michigan
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1056, Detroit
- Ascentage Investigative Site #1023, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- and 71 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
- The Barbara Ann Karmanos Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT04838041Asciminib Roll-over Study
- Michigan Med University of Michigan, Ann Arbor
RecruitingPhase 4
Ages 7 to 100 · All sexes · Updated Jul 6, 2026 · NCT04877522A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Michigan, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Karmanos Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 to 66 · All sexes · Updated Mar 17, 2026 · NCT06859424HPC Offered for PRESERVE Expansion
- Henry Ford Health, Detroit
RecruitingObservational study
Ages 12 to 80 · All sexes · Updated Aug 28, 2025 · NCT07145411From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.